Comparison of bioresorbable vs durable polymer drug-eluting stents in unprotected left main (from the RAIN-CARDIOGROUP VII Study)

Intracoronary versus intravenous adenosine to assess fractional flow reserve

(2018) Sebastiano Gili et al.   Journal of Cardiovascular Medicine

Outcomes of patients treated with ultrathin-strut biodegradable polymer sirolimus-eluting stents versus fluoropolymer-based everolimus-eluting stents: a meta-analysis of randomised trials

(2018) Salvatore Cassese et al.   EuroIntervention

Ultrathin strut biodegradable-polymer sirolimus-eluting stents: being wary or going with the flow?

(2018) Salvatore Cassese et al.   Journal of Thoracic Disease

Two-year clinical outcome of all-comers treated with three highly dissimilar contemporary coronary drug-eluting stents in the randomised BIO-RESORT trial

(2018) Marlies M. Kok et al.   EuroIntervention

Impact of design of coronary stents and length of dual antiplatelet therapies on ischaemic and bleeding events: a network meta-analysis of 64 randomized controlled trials and 102 735 patients

(2017) Fabrizio D’Ascenzo et al.   EUROPEAN HEART JOURNAL

2017 ESC focused update on dual antiplatelet therapy in coronary artery disease developed in collaboration with EACTS

(2017) Marco Valgimigli et al.   EUROPEAN HEART JOURNAL

Meta-Analysis of Randomized Clinical Trials Comparing Biodegradable Polymer Drug-Eluting Stent to Second-Generation Durable Polymer Drug-Eluting Stents

(2017) Georges El-Hayek et al.   JACC-Cardiovascular Interventions

Biodegradable Polymer Biolimus-Eluting Stents Versus Durable Polymer Everolimus-Eluting Stents in Patients With Coronary Artery Disease

(2017) Georgios J. Vlachojannis et al.   JACC-Cardiovascular Interventions

Healthy and diseased coronary bifurcation geometries influence near-wall and intravascular flow: A computational exploration of the hemodynamic risk

(2017) Claudio Chiastra et al.   JOURNAL OF BIOMECHANICS

Ultrathin, bioresorbable polymer sirolimus-eluting stents versus thin, durable polymer everolimus-eluting stents in patients undergoing coronary revascularisation (BIOFLOW V): a randomised trial

(2017) David E Kandzari et al.   LANCET

Clinical outcomes of bioresorbable versus durable polymer-coated everolimus-eluting stents in real-world complex patients

(2017) Marco Mennuni et al.   EuroIntervention

Provisional vs. two-stent technique for unprotected left main coronary artery disease after ten years follow up: A propensity matched analysis

(2016) Fabrizio D'Ascenzo et al.   INTERNATIONAL JOURNAL OF CARDIOLOGY

Contemporary Approach to Coronary Bifurcation Lesion Treatment

(2016) Fadi J. Sawaya et al.   JACC-Cardiovascular Interventions

Accuracy of intravascular ultrasound and optical coherence tomography in identifying functionally significant coronary stenosis according to vessel diameter: A meta-analysis of 2,581 patients and 2,807 lesions

(2015) Fabrizio D'Ascenzo et al.   AMERICAN HEART JOURNAL

Efficacy and Safety of a Novel Bioabsorbable Polymer-Coated, Everolimus-Eluting Coronary Stent: The EVOLVE II Randomized Trial

(2015) D. J. Kereiakes et al.   Circulation-Cardiovascular Interventions

Long-Term Clinical Outcomes of Final Kissing Ballooning in Coronary Bifurcation Lesions Treated With the 1-Stent Technique

(2015) Cheol Woong Yu et al.   JACC-Cardiovascular Interventions

Clinical Outcome After DK Crush Versus Culotte Stenting of Distal Left Main Bifurcation Lesions

(2015) Shao-Liang Chen et al.   JACC-Cardiovascular Interventions

Final 5-Year Follow-Up of a Randomized Controlled Trial of Everolimus- and Paclitaxel-Eluting Stents for Coronary Revascularization in Daily Practice

(2015) Pieter C. Smits et al.   JACC-Cardiovascular Interventions

Biodegradable-polymer drug-eluting stents vs. bare metal stents vs. durable-polymer drug-eluting stents: a systematic review and Bayesian approach network meta-analysis

(2014) S.-H. Kang et al.   EUROPEAN HEART JOURNAL

Impact of the Complexity of Bifurcation Lesions Treated With Drug-Eluting Stents

(2014) Shao-Liang Chen et al.   JACC-Cardiovascular Interventions

Discontinuation of Dual Antiplatelet Therapy Over 12 Months after Acute Coronary Syndromes Increases Risk for Adverse Events in Patients Treated with Percutaneous Coronary Intervention: Systematic Review and Meta-Analysis

(2014) FABRIZIO D'ASCENZO et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Improved Safety and Reduction in Stent Thrombosis Associated With Biodegradable Polymer-Based Biolimus-Eluting Stents Versus Durable Polymer-Based Sirolimus-Eluting Stents in Patients With Coronary Artery Disease

(2013) Patrick W. Serruys et al.   JACC-Cardiovascular Interventions

Safety and efficacy outcomes of first and second generation durable polymer drug eluting stents and biodegradable polymer biolimus eluting stents in clinical practice: comprehensive network meta-analysis

(2013) E. P. Navarese et al.   BMJ-British Medical Journal

Bare metal stents, durable polymer drug eluting stents, and biodegradable polymer drug eluting stents for coronary artery disease: mixed treatment comparison meta-analysis

(2013) S. Bangalore et al.   BMJ-British Medical Journal

Use and Misuse of Multivariable Approaches in Interventional Cardiology Studies on Drug-Eluting Stents: A Systematic Review

(2012) FABRIZIO D’ASCENZO et al.   JOURNAL OF INTERVENTIONAL CARDIOLOGY

Stent Thrombogenicity Early in High-Risk Interventional Settings Is Driven by Stent Design and Deployment and Protected by Polymer-Drug Coatings

(2011) Kumaran Kolandaivelu et al.   CIRCULATION

The outcome of bifurcation lesion stenting using a biolimus-eluting stent with a bio-degradable polymer compared to a sirolimus-eluting stent with a durable polymer

(2011) Scot Garg et al.   EuroIntervention